The author presents a reference for diagnostic radiology, radiation oncology, and nuclear medicine. The book includes subjects such as physics, basic biolo...
The long-term survival of patients with advanced stage aggressive lymphoma has not improved significantly during the last twenty years. In a randomised tri...
BACKGROUND: Patients with clinically localized, intermediate- or high-grade non-Hodgkin's lymphoma usually receive initial treatment with a doxorubicin-containing regimen such as cyclophosphamide, doxorubicin, vincristine, and prednisone...
BACKGROUND: Patients with clinically localized, intermediate- or high-grade non-Hodgkin's lymphoma usually receive initial treatment with a doxorubicin-containing regimen such as cyclophosphamide, doxorubicin, vincristine, and prednisone...
An international multi-institutional clinicopathologic study of 1175 cases of non-Hodgkin's lymphoma sponsored by the National Cancer Institute has been co...
PURPOSE: The purpose of this study was to evaluate the possible effect of adjunctive involved field (IF) radiotherapy on long-term local control for patien...
Summary A new staging system for intermediate grade lym-phomas and immunoblastic lymphomas is described. This system is based on the tumor score which cons...
In order to improve the prognosis of patients with localized non-Hodgkin's lymphomas (NHL) who are treated with radiotherapy (RT), a prospective controlled...
A single institution's experience with the treatment of localized primary malignant lymphoma of bone (PLB) was analyzed to identify major prognostic factor...
